ArticleJournal of Alzheimer's disease : JAD2017

Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid.

Nicola Voyle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.